NEW YORK (Reuters) - Colgate Palmolive is looking at ways to reduce the impact of possible tariffs on its toothpastes, which ...

Colgate-Palmolive’s CEO noted that the company hit an “exciting milestone,” but it wasn’t enough to lift the stock premarket.

Colgate-Palmolive reported stable earnings for Q4 2024, beating EPS estimates but just missing revenue expectations.

"Our (sales) guidance includes the impact of the planned exit from private label pet nutrition over the course of 2025," said ...

Q4 2024 Management View CEO Noel Wallace highlighted net sales of $20 billion in 2024, achieving this milestone one year ...

Shares of Colgate-Palmolive (NYSE: CL) pulled back today after the household products giant missed the mark on the top line ...

Buying Colgate-Palmolive Company shares after their 20% drop may not be a good idea for dividend or total return investors.

Colgate-Palmolive reported a slight decline in Q4 sales, dropping 0.12% to $4.94 billion, missing estimates. However, organic ...

We recently published a list of 12 Best Defensive Stocks To Buy Right Now. In this article, we are going to take a look at where Colgate-Palmolive Company (NYSE:CL) stands against other best defensive ...

Colgate-Palmolive Co. shares are down 3.8% in premarket trades despite the toothpaste and toothbrush giant reporting better-than-expected fourth-quarter profit and hitting a full-year revenue ...

Consumer products company Colgate-Palmolive (CL) saw its stock drop today following the release of its Q4 2024 earnings report. The bad news ...

Colgate-Palmolive forecast 2025 sales to be roughly flat from last year; sales came in at $20.10 billion in 2024. Write to Denny Jacob at [email protected] ...